Mary Couper

621 total citations
9 papers, 451 citations indexed

About

Mary Couper is a scholar working on Economics and Econometrics, Toxicology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mary Couper has authored 9 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Economics and Econometrics, 3 papers in Toxicology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mary Couper's work include Pharmaceutical Economics and Policy (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Pharmaceutical Quality and Counterfeiting (2 papers). Mary Couper is often cited by papers focused on Pharmaceutical Economics and Policy (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Pharmaceutical Quality and Counterfeiting (2 papers). Mary Couper collaborates with scholars based in Switzerland, Sweden and Ghana. Mary Couper's co-authors include Sten Olsson, Kees van Grootheest, Lolkje de Jong‐van den Berg, Shanthi Pal, Andy Stergachis, Robin J.M. Gray, HV Hogerzeil, Dinesh Kumar Mehta, Sam Adjei and Ralph Edwards and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Drug Safety.

In The Last Decade

Mary Couper

9 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Couper Switzerland	8	199	133	113	106	77	9	451
Gurumurthy Parthasarathi India	13	118 0.6×	65 0.5×	89 0.8×	125 1.2×	45 0.6×	32	467
Ronald Kiguba Uganda	13	151 0.8×	67 0.5×	116 1.0×	69 0.7×	89 1.2×	41	498
Alexander Dodoo Ghana	17	265 1.3×	250 1.9×	191 1.7×	75 0.7×	270 3.5×	47	907
Alex Dodoo Ghana	10	131 0.7×	84 0.6×	65 0.6×	31 0.3×	138 1.8×	14	406
Leàn Rolfes Netherlands	11	270 1.4×	110 0.8×	103 0.9×	71 0.7×	25 0.3×	23	386
Teferi Gedif Ethiopia	14	61 0.3×	57 0.4×	76 0.7×	43 0.4×	101 1.3×	35	725
RK Dikshit India	10	151 0.8×	56 0.4×	48 0.4×	56 0.5×	36 0.5×	25	364
Furqan K. Hashmi Pakistan	12	52 0.3×	111 0.8×	48 0.4×	85 0.8×	45 0.6×	21	425
Bertrand Guignard Switzerland	11	52 0.3×	63 0.5×	74 0.7×	221 2.1×	24 0.3×	30	428
Elisângela da Costa Lima Brazil	11	52 0.3×	43 0.3×	70 0.6×	38 0.4×	72 0.9×	46	379

Countries citing papers authored by Mary Couper

Since Specialization

Citations

This map shows the geographic impact of Mary Couper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Couper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Couper more than expected).

Fields of papers citing papers by Mary Couper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Couper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Couper. The network helps show where Mary Couper may publish in the future.

Co-authorship network of co-authors of Mary Couper

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Couper. A scholar is included among the top collaborators of Mary Couper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Couper. Mary Couper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Olsson, Sten, Shanthi Pal, Andy Stergachis, & Mary Couper. (2010). Pharmacovigilance Activities in 55 Low- and Middle-Income Countries. Drug Safety. 33(8). 689–703. 128 indexed citations

2.

Ofori‐Adjei, David, et al.. (2008). A review of the safety of niclosamide, pyrantel, triclabendazole and oxamniquine. International Journal of Risk & Safety in Medicine. 20(3). 113–122. 17 indexed citations

3.

Adjei, Sam, et al.. (2007). When rumours derail a mass deworming exercise. The Lancet. 370(9586). 465–466. 26 indexed citations

4.

Grootheest, Kees van, Sten Olsson, Mary Couper, & Lolkje de Jong‐van den Berg. (2003). Pharmacists' role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiology and Drug Safety. 13(7). 457–464. 138 indexed citations

5.

Couper, Mary, et al.. (2002). WHO model formulary. World Health Organization eBooks. 1 indexed citations

6.

Couper, Mary & Dinesh Kumar Mehta. (2002). WHO model formulary 2002. Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG)). 32 indexed citations

7.

Couper, Mary. (1997). Strategies for the Rational Use of Antimicrobials. Clinical Infectious Diseases. 24(Supplement_1). S154–S156. 41 indexed citations

8.

Hogerzeil, HV, Mary Couper, & Robin J.M. Gray. (1997). Guidelines for drug donations. BMJ. 314(7082). 737–737. 52 indexed citations

9.

Couper, Mary, et al.. (1975). Housing Classes and Housing Values. The Sociological Review. 23(3). 563–576. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact